Hong Kong stocks close with Hang Seng Index down 1.73% and Hang Seng Tech Index down 3.27%.
Following the resumption of trading after the Golden Week holiday, Hong Kong's stock market posted mixed results today. The Hang Seng Index closed down 1.73%, or 76.87 points, to 26,752.59 points, while the Hang Seng Tech Index fell 3.27%, or 209.35 points, to 6,471.34 points . The Hang Seng China Enterprises Index, however, rose 0.07% to 9,530.13 points.
The performance of blue-chip stocks was varied. Hang Seng Bank (00011) led the blue chips higher, surging 25.88% to HKD 149.8, contributing 36.11 points to the Hang Seng Index. Lenovo Group (00992) rose 7.26% to HKD 12.56, while Zijin Mining (02899) gained 5.43% to HKD 36.14. On the other hand, Sino Biopharm (01177) dropped 7.49% to HKD 7.9, and SMIC (00981) fell 6.7% to HKD 83.5 .
Large technology stocks showed mixed performance, with Kuaishou rising over 3%, NetEase and Tencent posting modest gains, while Alibaba fell more than 2%. Metals such as gold, silver, copper, and aluminum surged significantly during the dual holidays, driving broad strength in metal-related stocks today. China Gold International was added to the Hang Seng Hong Kong Red Chip Index, with its share price surging over 9% to a new high. AI concept stocks showed mixed performance, with Lenovo Group (00992) rising 7.26% to HKD 12.56, while Alibaba-W (09988) fell 2.42% to HKD 173.3 .
Pharmaceutical stocks led declines, with Clover Biopharmaceuticals-B (02197) dropping 13.4% to HKD 2.52, and InnoCare Pharma (09969) falling 11.64% to HKD 16.62. Chip stocks plummeted in the afternoon, with SMIC (00981) falling 6.7% to HKD 83.5, and Huahong Semiconductor (01347) declining 6.43% to HKD 85.2 .
Hot movers included Shanghai Electric (02727), which surged 17.4% to HKD 5.6, and Goldwind Technology (02208), which closed up 8.43% at HKD 15.57. HSBC Holdings (00005) faced downward pressure, closing down 5.97% at HKD 104, following the announcement of its plan to privatize Hang Seng Bank through a scheme of arrangement .
Comments
No comments yet